What do we mean by vaginal and urinary changes?
The previously used term was vulvovaginal atrophy (VVA).
- Vaginal dryness
- Vaginal itchiness
- Painful sex
- Burning
- Painful urination (dysuria)
- Urinary frequency or urgency
- Trouble holding urine
- UTIs
- Discomfort during pelvic exams – especially speculum exams
3 things to know about vaginal & urinary changes
-
Vaginal changes usually begin with irritation, itching, dryness and pain with sex.
-
Too many women and their healthcare providers are uncomfortable talking about vulvovaginal changes so this important topic doesn’t get discussed.
-
Vulvar and vaginal changes don’t get better over time. If you are experiencing either, talk to your healthcare provider. These changes are treatable.
The menopausal transition has been a difficult one — one that I am still challenged by — particularly with respect to vaginal changes. When you were once very sexual and enjoyed intercourse and suddenly that changes, it’s quite a loss. It’s very hard now to associate pleasure with intercourse, as it has become painful despite the lubricants. Be creative and buy a vibrator!WLB Community Member
These data represent the % of respondents reporting each symptom on the Women Living Better Survey. LRS stands for the late reproductive stage and MT for the Menopause Transition. These are two stages on the path to menopause (the final menstrual period).
Vaginal Changes
Pain with vaginal sex
Less vaginal lubrication
Vaginal dryness
Vaginal itchiness
Urinary Changes
Urinary leakage with sneezing or cough
Urinary leakage at other times
Increased frequency of urinating
Urinary urgency
Genitourinary syndrome of menopause affects approximately 27% to 84% of postmenopausal women and can significantly impair health, sexual function, and quality of life.The North American Menopause Society (NAMS) 2020 Position Statement
This seems like a very wide range and might have to do with the various ways questions about GSM are asked in research.
Hormones & vulvar and vaginal changes
Vulvar and vaginal changes tend to begin in the later stages of perimenopause, closer to the final menstrual period, when estrogen levels are declining, although for some women these symptoms do not appear until a year or more after the final menstrual period.
Estrogen makes vaginal tissues moist and flexible and increases lubrication during arousal. Without this lubrication, penetration can become painful. As we experience lower levels of estrogen over time, vaginal symptoms can get worse so talk to your healthcare provider if you experience these symptoms.
The thinner, more fragile vulvovaginal tissue in combination with lower immunity associated with aging, can lead to more urinary tract infections (UTIs).
Remedies to help with vulvar and vaginal changes
OVER THE COUNTER
Moisturizers can relieve irritation
Lubricants to minimize friction during sex
BY PRESCRIPTION
Vaginal Estradiol can re-invigorate vaginal tissue
Selective Estrogen Receptor Modulators can treat painful sex and discomfort
DHEA is a non-estrogen treatment for GSM and painful sex
IN-OFFICE TREATMENT
Laser or radiofrequency treatments claim to rehabilitate vagina tissue
A recent 2022 systematic review concluded: that CO2-Lasers are a safe therapeutic option for the management of GSM symptoms in postmenopausal women; but noted that “the quality of the body of evidence is “very low” or “low”.”
I always tell patients that the package insert for vaginal estrogen (topical) is the same as for oral estrogen and it can be scary to read the risks/warnings. However, research documents that applying estrogen vaginally results in lower systemic levels, not the same as when you take it orally. I also warn them that insurance coverage for vaginal estrogen varies widely and it can be very expensive.Dr. Marcie Richardson
ObGyn Founder, Menopause Clinic, Atrius Health, Boston
REFERENCES
- Vale F, Rezende C, Raciclan A, Bretas T, Geber S. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction. Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:92-95. doi: 10.1016/j.ejogrb.2018.12.040. Epub 2019 Jan 11.
- Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel, Menopause. 2014 Oct;21(10):1063-8)
- Hussain I, Talaulikar VS. A systematic review of randomized clinical trials – The safety of vaginal hormones and selective estrogen receptor modulators for the treatment of genitourinary menopausal symptoms in breast cancer survivors. Post Reprod Health. 2023 Oct 16:20533691231208473. doi: 10.1177/20533691231208473. Epub ahead of print. PMID: 37840298.
- Filippini M, Porcari I, Ruffolo AF, Casiraghi A, Farinelli M, Uccella S, Franchi M, Candiani M, Salvatore S. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis. J Sex Med. 2022 Mar;19(3):452-470. doi: 10.1016/j.jsxm.2021.12.010. Epub 2022 Jan 29. PMID: 35101378.